The owner of the U.S.’ largest pharmacy benefit manager won't cover Gilead Sciences’ long-acting HIV prevention drug Yeztugo, at least for now.

Trichomoniasis is a common, treatable STI, but testing is the only way to know if you’re infected. Discover our pick of the best at-home trichomoniasis tests here.

CVS Health (CVS) won't include Gilead's (GILD) new HIV drug Yeztugo in its commercial healthcare plans, due to clinical, regulatory and financial factors. Read more here.

CVS Health, one of the nation’s largest pharmacy benefit manager companies that play a lead role in deciding which drugs are covered by health insurance plans, has initially decided not to ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the ...

CVS Health, one of the nation’s largest pharmacy benefit managers, has declined to cover Gilead’s newly FDA-approved HIV prevention drug Yeztugo (lenacapavir), a twice-yearly injection shown ...

How STDcheck.com works and our tester’s experience STDcheck’s STD Test Recommender tool evaluates which tests you need based on your answers to a few sexual health questions.

Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.

You may soon be able to collect your own sample for an HPV test at home using the Teal Health cervical cancer screening device.

The HIV epidemic in the Philippines continues to escalate, with new cases increasing by 500 percent over the past decade. Health experts warn that the number of Filipinos living with HIV could exceed ...